abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to the chemical-pharmaceutical industry and represents a substance-delivering carrier for the substance delivery to a bone marrow cell producing an extracellular matrix containing retinoid as a delivering agent, wherein the substance is a therapeutic agent, which inhibits the beginning, progression and/or recurrence of myelofibrosis. n EFFECT: invention provides the effective inhibition of the beginning, progression and recurrence of myelofibrosis. n 10 cl, 14 dwg, 8 ex |